Global Neurological Biomarkers Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	175 Pages	TechNavio	February, 2024	INF18598434

Best Price Guarantee
Price	from $2,500
Length	175 Pages
Publisher	TechNavio
Published Date	February, 2024
SKU	INF18598434

Global Neurological Biomarkers Market 2024-2028

The neurological biomarkers market is forecasted to grow by USD 7.82 bn during 2023-2028, accelerating at a CAGR of 13.01% during the forecast period. The report on the neurological biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growth in clinical trials for neurological disease-specific biomarkers, and increasing initiatives and support from governments to improve neurological healthcare access.

Technavio's neurological biomarkers market is segmented as below:

By End-user

Hospitals
Clinical diagnostic centers
Research organizations and others

By Indication

AD
PD
ASD
MS
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing focus on accurate neurological diagnostics as one of the prime reasons driving the neurological biomarkers market growth during the next few years. Also, growing availability of blood-based biomarkers and evolution of manual miRNA will lead to sizable demand in the market.

The report on the neurological biomarkers market covers the following areas:

Neurological biomarkers market sizing
Neurological biomarkers market forecast
Neurological biomarkers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurological biomarkers market vendors that include Abbott Laboratories, ACROBIOSYSTEMS INC., Advanced Brain Monitoring Inc., Alseres Pharmaceuticals Inc, Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories International Inc., EATRIS ERIC, Eli Lilly and Co., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., IQVIA Holdings Inc., Merck KGaA, Metabolon Inc., PerkinElmer Inc, Proteome Sciences plc, QIAGEN NV, Quanterix Corp., and Thermo Fisher Scientific Inc.. Also, the neurological biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Chart on Market Overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Chart on Global Market Characteristics
  - Table Executive Summary - Chart on Market by Geography
  - Table Executive Summary - Chart on Market Segmentation by End-user
  - Table Executive Summary - Chart on Market Segmentation by Indication
  - Table Executive Summary - Chart on Incremental Growth
  - Table Executive Summary - Data Table on Incremental Growth
  - Table Executive Summary - Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global neurological biomarkers market 2018 - 2022
  - Table Historic Market Size - Data Table on global neurological biomarkers market 2018 - 2022 ($ million)
- End-user Segment Analysis 2018 - 2022
  - Table Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- Indication Segment Analysis 2018 - 2022
  - Table Historic Market Size - Indication Segment 2018 - 2022 ($ million)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size - Country Segment 2018 - 2022 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants - Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes - Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry - Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by End-user
- Market segments
  - Table Chart on End-user - Market share 2023-2028 (%)
  - Table Data Table on End-user - Market share 2023-2028 (%)
- Comparison by End-user
  - Table Chart on Comparison by End-user
  - Table Data Table on Comparison by End-user
- Hospitals - Market size and forecast 2023-2028
  - Table Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
- Clinical diagnostic centers - Market size and forecast 2023-2028
  - Table Chart on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
- Research organizations and others - Market size and forecast 2023-2028
  - Table Chart on Research organizations and others - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Research organizations and others - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Research organizations and others - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Research organizations and others - Year-over-year growth 2023-2028 (%)
- Market opportunity by End-user
  - Table Market opportunity by End-user ($ million)
  - Table Data Table on Market opportunity by End-user ($ million)
Market Segmentation by Indication
- Market segments
  - Table Chart on Indication - Market share 2023-2028 (%)
  - Table Data Table on Indication - Market share 2023-2028 (%)
- Comparison by Indication
  - Table Chart on Comparison by Indication
  - Table Data Table on Comparison by Indication
- AD - Market size and forecast 2023-2028
  - Table Chart on AD - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on AD - Market size and forecast 2023-2028 ($ million)
  - Table Chart on AD - Year-over-year growth 2023-2028 (%)
  - Table Data Table on AD - Year-over-year growth 2023-2028 (%)
- PD - Market size and forecast 2023-2028
  - Table Chart on PD - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on PD - Market size and forecast 2023-2028 ($ million)
  - Table Chart on PD - Year-over-year growth 2023-2028 (%)
  - Table Data Table on PD - Year-over-year growth 2023-2028 (%)
- ASD - Market size and forecast 2023-2028
  - Table Chart on ASD - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on ASD - Market size and forecast 2023-2028 ($ million)
  - Table Chart on ASD - Year-over-year growth 2023-2028 (%)
  - Table Data Table on ASD - Year-over-year growth 2023-2028 (%)
- MS - Market size and forecast 2023-2028
  - Table Chart on MS - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on MS - Market size and forecast 2023-2028 ($ million)
  - Table Chart on MS - Year-over-year growth 2023-2028 (%)
  - Table Data Table on MS - Year-over-year growth 2023-2028 (%)
- Others - Market size and forecast 2023-2028
  - Table Chart on Others - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Others - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Others - Year-over-year growth 2023-2028 (%)
- Market opportunity by Indication
  - Table Market opportunity by Indication ($ million)
  - Table Data Table on Market opportunity by Indication ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ million)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- China - Market size and forecast 2023-2028
  - Table Chart on China - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on China - Market size and forecast 2023-2028 ($ million)
  - Table Chart on China - Year-over-year growth 2023-2028 (%)
  - Table Data Table on China - Year-over-year growth 2023-2028 (%)
- France - Market size and forecast 2023-2028
  - Table Chart on France - Market size and forecast 2023-2028 ($ million)
  - Table Data Table on France - Market size and forecast 2023-2028 ($ million)
  - Table Chart on France - Year-over-year growth 2023-2028 (%)
  - Table Data Table on France - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Rising incidence of neurological disorders
  - Growth in clinical trials for neurological disease-specific biomarkers
  - Increasing initiatives and support from governments to improve neurological healthcare access
- Market challenges
  - Unmet market needs for effective validation of biomarkers
  - Reproducibility of biomarkers and tests leading to discrepancies
  - Inherent challenges in neurological research
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Increasing focus on accurate neurological diagnostics
  - Growing availability of blood-based biomarkers
  - Evolution of manual miRNA
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Abbott Laboratories
  - Table Abbott Laboratories - Overview
  - Table Abbott Laboratories - Business segments
  - Table Abbott Laboratories - Key news
  - Table Abbott Laboratories - Key offerings
  - Table Abbott Laboratories - Segment focus
- ACROBIOSYSTEMS INC.
  - Table ACROBIOSYSTEMS INC. - Overview
  - Table ACROBIOSYSTEMS INC. - Product / Service
  - Table ACROBIOSYSTEMS INC. - Key offerings
- Alseres Pharmaceuticals Inc
  - Table Alseres Pharmaceuticals Inc - Overview
  - Table Alseres Pharmaceuticals Inc - Product / Service
  - Table Alseres Pharmaceuticals Inc - Key offerings
- Bio Rad Laboratories Inc.
  - Table Bio Rad Laboratories Inc. - Overview
  - Table Bio Rad Laboratories Inc. - Business segments
  - Table Bio Rad Laboratories Inc. - Key news
  - Table Bio Rad Laboratories Inc. - Key offerings
  - Table Bio Rad Laboratories Inc. - Segment focus
- bioMerieux SA
  - Table bioMerieux SA - Overview
  - Table bioMerieux SA - Product / Service
  - Table bioMerieux SA - Key news
  - Table bioMerieux SA - Key offerings
- Eli Lilly and Co.
  - Table Eli Lilly and Co. - Overview
  - Table Eli Lilly and Co. - Product / Service
  - Table Eli Lilly and Co. - Key news
  - Table Eli Lilly and Co. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- IQVIA Holdings Inc.
  - Table IQVIA Holdings Inc. - Overview
  - Table IQVIA Holdings Inc. - Business segments
  - Table IQVIA Holdings Inc. - Key news
  - Table IQVIA Holdings Inc. - Key offerings
  - Table IQVIA Holdings Inc. - Segment focus
- Merck KGaA
  - Table Merck KGaA - Overview
  - Table Merck KGaA - Business segments
  - Table Merck KGaA - Key news
  - Table Merck KGaA - Key offerings
  - Table Merck KGaA - Segment focus
- Metabolon Inc.
  - Table Metabolon Inc. - Overview
  - Table Metabolon Inc. - Product / Service
  - Table Metabolon Inc. - Key offerings
- PerkinElmer Inc
  - Table PerkinElmer Inc - Overview
  - Table PerkinElmer Inc - Business segments
  - Table PerkinElmer Inc - Key news
  - Table PerkinElmer Inc - Key offerings
  - Table PerkinElmer Inc - Segment focus
- Proteome Sciences plc
  - Table Proteome Sciences plc - Overview
  - Table Proteome Sciences plc - Product / Service
  - Table Proteome Sciences plc - Key offerings
- QIAGEN NV
  - Table QIAGEN NV - Overview
  - Table QIAGEN NV - Product / Service
  - Table QIAGEN NV - Key news
  - Table QIAGEN NV - Key offerings
- Quanterix Corp.
  - Table Quanterix Corp. - Overview
  - Table Quanterix Corp. - Product / Service
  - Table Quanterix Corp. - Key offerings
- Thermo Fisher Scientific Inc.
  - Table Thermo Fisher Scientific Inc. - Overview
  - Table Thermo Fisher Scientific Inc. - Business segments
  - Table Thermo Fisher Scientific Inc. - Key news
  - Table Thermo Fisher Scientific Inc. - Key offerings
  - Table Thermo Fisher Scientific Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations